Latest Semaglutide News and Updates : Semaglutide updates, Semaglutide News , Semaglutide around the world

Nishadil

Washington | 26°C (scattered clouds)

A Glimmer of Hope for Longer, Healthier Lives? Popular Diabetes Drug Shows Striking Potential in Aging Mice

Top story

A Glimmer of Hope for Longer, Healthier Lives? Popular Diabetes Drug Shows Striking Potential in Aging Mice

In focus

Latest feed

A New Hope: How 'Obesity Drugs' Are Revolutionizing Treatment for PMOS

Dubai's Wellness Frontier: Unpacking the Viral World of Peptides

Your Daily Buzz, GLP-1 Side Effects, and a Cosmic Spectacle: What You Need to Know

India's Landmark Approval: Wegovy Cleared for MASH, a Serious Liver Condition

Latest headlines

Wegovy Gets Green Light in India as First‑Line Treatment for MASH, the Liver Condition Touching One‑Third of Indians

Wegovy Gets Green Light in India as First‑Line Treatment for MASH, the Liver Condition Touching One‑Third of Indians

Do Weight‑Loss Drugs Really Cut Cancer Risk? A Cautious Look at the Evidence

Do Weight‑Loss Drugs Really Cut Cancer Risk? A Cautious Look at the Evidence

Beyond Weight Loss: Could Ozempic and Mounjaro Actually Slow Down Aging?

Beyond Weight Loss: Could Ozempic and Mounjaro Actually Slow Down Aging?

The Bizarre Case: How a Diet Soda Melted a Stomach Mass, Possibly Linked to Popular Weight-Loss Drugs

The Bizarre Case: How a Diet Soda Melted a Stomach Mass, Possibly Linked to Popular Weight-Loss Drugs

A Glimmer of Hope: How Weight-Loss Drugs Might Save Limbs

A Glimmer of Hope: How Weight-Loss Drugs Might Save Limbs

The Next Frontier: How Pharma is Redefining GLP-1 Success Beyond the Pill

The Next Frontier: How Pharma is Redefining GLP-1 Success Beyond the Pill

Pharma’s New Playbook: Merging Nutrition with GLP‑1 Therapy

Pharma’s New Playbook: Merging Nutrition with GLP‑1 Therapy

Do GLP‑1 Medications Raise Testosterone? What the Science Actually Shows

Do GLP‑1 Medications Raise Testosterone? What the Science Actually Shows

Semaglutide Generics: Can API Capacity Turn the Tide?

Semaglutide Generics: Can API Capacity Turn the Tide?

The Road Ahead for Semaglutide Generics: Why API Capacity Is the Real Game‑Changer, Says Goldman Sachs

The Road Ahead for Semaglutide Generics: Why API Capacity Is the Real Game‑Changer, Says Goldman Sachs

Medicare’s $50 GLP‑1 Weight‑Loss Plan: What the Numbers Really Mean

Medicare’s $50 GLP‑1 Weight‑Loss Plan: What the Numbers Really Mean

Can Wegovy Really Shift New Zealand’s Obesity Landscape?

Can Wegovy Really Shift New Zealand’s Obesity Landscape?

A Closer Look: Are Popular Weight-Loss Drugs Linked to a Rare Eye Condition?

A Closer Look: Are Popular Weight-Loss Drugs Linked to a Rare Eye Condition?

The Curious Case of Ozempic's Canadian Patent: A Legal Time Bomb?

The Curious Case of Ozempic's Canadian Patent: A Legal Time Bomb?

India's Beauty Under Siege: The Urgent Crackdown on Unsafe Injectables and Wellness Drips

India's Beauty Under Siege: The Urgent Crackdown on Unsafe Injectables and Wellness Drips

Navigating Weight Loss Solutions for Adults with Asthma

Navigating Weight Loss Solutions for Adults with Asthma

Navigating Weight Loss Medications: A Comprehensive Guide for Adults with Asthma

Navigating Weight Loss Medications: A Comprehensive Guide for Adults with Asthma

A Game Changer for Canadians? Dr. Reddy's Unveils Generic Semaglutide Injection

A Game Changer for Canadians? Dr. Reddy's Unveils Generic Semaglutide Injection

A Surprising Turn: Could Weight Loss Drugs Offer Hope for Alcohol Addiction?

A Surprising Turn: Could Weight Loss Drugs Offer Hope for Alcohol Addiction?

The Unexpected Hope: How a Weight Loss Drug Might Be Tackling Alcohol Cravings

The Unexpected Hope: How a Weight Loss Drug Might Be Tackling Alcohol Cravings

A Glimmer of Hope for Fatty Liver Disease? Popular Medicines Show Promising Reversal Effects

A Glimmer of Hope for Fatty Liver Disease? Popular Medicines Show Promising Reversal Effects

The Delhi Drug Clampdown: Ensuring Safety in the Rush for Weight Loss

The Delhi Drug Clampdown: Ensuring Safety in the Rush for Weight Loss

The Alarming Rise: GLP-1 Drugs Misused for Cosmetic Weight Loss in India

The Alarming Rise: GLP-1 Drugs Misused for Cosmetic Weight Loss in India

Innovation Over Imitation: Novo Nordisk's Bold Bet in India's Healthcare Landscape

Innovation Over Imitation: Novo Nordisk's Bold Bet in India's Healthcare Landscape

The Semaglutide Surge: Unpacking India's New Weight Loss Frontier

The Semaglutide Surge: Unpacking India's New Weight Loss Frontier

The Next Big Leap: Indian Pharma's Race for the Semaglutide Jackpot

The Next Big Leap: Indian Pharma's Race for the Semaglutide Jackpot

A Game Changer for Health: Generic Semaglutide Slashes Prices in India, Offering New Hope

A Game Changer for Health: Generic Semaglutide Slashes Prices in India, Offering New Hope

The Heart of the Matter: Do GLP-1 Medications Offer Lasting Protection, Or Is It A Momentary Truce?

The Heart of the Matter: Do GLP-1 Medications Offer Lasting Protection, Or Is It A Momentary Truce?

GLP-1 Medications: The Unveiling Truth About Sustaining Heart Health Benefits

GLP-1 Medications: The Unveiling Truth About Sustaining Heart Health Benefits

GLP-1 Medications: A Lifelong Partnership for Heart Health?

GLP-1 Medications: A Lifelong Partnership for Heart Health?

From Venom to Vital Medicine: The Unlikely Tale of the Gila Monster and Ozempic

From Venom to Vital Medicine: The Unlikely Tale of the Gila Monster and Ozempic

The Shadow Side of Breakthroughs: A Tragic Ozempic Lawsuit Unveils Concerns Over Patient Safety

The Shadow Side of Breakthroughs: A Tragic Ozempic Lawsuit Unveils Concerns Over Patient Safety

A New Chapter in Obesity Care: Novo Nordisk and Hims & Hers Team Up for Broader Access

A New Chapter in Obesity Care: Novo Nordisk and Hims & Hers Team Up for Broader Access

The Looming Obesity Crisis: How New Weight Loss Drugs Like Ozempic Are Changing the Game

The Looming Obesity Crisis: How New Weight Loss Drugs Like Ozempic Are Changing the Game

CagriSema: Is Novo Nordisk's New Weight-Loss Drug the Breakthrough We've Been Waiting For?

CagriSema: Is Novo Nordisk's New Weight-Loss Drug the Breakthrough We've Been Waiting For?

The 'Skinny Pen' Phenomenon: A Look at India's Weight Loss Drug Revolution

The 'Skinny Pen' Phenomenon: A Look at India's Weight Loss Drug Revolution

Navigating the Untamed Frontier: Why the GLP-1 Market Still Feels Like the Wild West

Navigating the Untamed Frontier: Why the GLP-1 Market Still Feels Like the Wild West

The Quiet Revolution: Ozempic, the Brain, and the End of 'Food Noise'

The Quiet Revolution: Ozempic, the Brain, and the End of 'Food Noise'

Load more